Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554099 · ClinicalTrials.gov registry record · Phase 2
Asacol Acute Diverticulitis(DIVA)Study
A Phase 2 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 2
- Development phase
- 117
- Enrollment target
NCT00554099 is a Phase 2 study that has completed, run by Warner Chilcott. The registered enrollment target is 117 participants.
The verdict
NCT00554099, a Phase 2 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 117 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg Mesalamine) is safe and effective in the treatment of diverticulitis.
Interventions
- DRUG Placebo
- DRUG Mesalamine
- DRUG Probiotic
- OTHER Dietary Advice
- DRUG Antibiotic for Diverticulitis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00554099
The ClinicalTrials.gov registry entry for NCT00554099 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00554099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00554099 about?
NCT00554099 is a clinical study titled "Asacol Acute Diverticulitis(DIVA)Study". The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg Mesalamine) is safe and effective in the treatment of diverticulitis.
What is the current status of trial NCT00554099?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 117 participants. The study started on 2007-11. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00554099?
The interventions under investigation include: Placebo (DRUG), Mesalamine (DRUG), Probiotic (DRUG), Dietary Advice (OTHER), Antibiotic for Diverticulitis (DRUG).
Who is sponsoring clinical trial NCT00554099?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.